title: Could tivozanib be a new potent pan-VEGF inhibitor in RCC therapy?
authors.affiliation: Research Laboratory for Pediatrics and Nephrology, Hungarian Academy of Sciences-Semmelweis University, Hungary.
authors.forename: Zsuzsanna
authors.initials: Z
authors.lastname: Mihály
authors.affiliation: Research Laboratory for Pediatrics and Nephrology, Hungarian Academy of Sciences-Semmelweis University, Hungary.
authors.forename: Alexisz
authors.initials: A
authors.lastname: Panajotu
authors.affiliation: Research Laboratory for Pediatrics and Nephrology, Hungarian Academy of Sciences-Semmelweis University, Hungary.
authors.forename: Balázs
authors.initials: B
authors.lastname: Győrffy
references.citation: J Natl Cancer Inst. 2012 Jan 18;104(2):93-113
references.pmid: 22235142
references.citation: J Clin Oncol. 2012 May 10;30(14):1678-85
references.pmid: 22493422
references.citation: Curr Cancer Drug Targets. 2012 Sep;12(7):857-72
references.pmid: 22515521